{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:34:44Z","timestamp":1759581284022},"reference-count":11,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,2]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> Early bone marrow transplant is now standard treatment for infants with severe immunodeficiencies such as Wiskott\u2013Aldrich Syndrome (WAS), but results in older children and adults are poor. Non\u2010myeloablative transplant has shown promise in the treatment of older children, who are likely to have active infections and organ damage. We describe a non\u2010myeloablative transplant of a 26\u2010year\u2010old man with WAS, undertaken because of severe infections and vasculitis. Partial engraftment and immunorestoration were achieved. The patient is well 1\u2003year post transplantation.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03269.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:42:11Z","timestamp":1047364931000},"page":"497-499","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non\u2010myeloablative bone marrow transplantation in an adult with Wiskott\u2013Aldrich syndrome"],"prefix":"10.1111","volume":"116","author":[{"given":"Hilary J.","family":"Longhurst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Taussig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzina","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise Syndercombe","family":"Court","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Cavenagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. David","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Helbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.4.1239"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.4049\/jimmunol.161.2.1026","article-title":"Monocytes from Wiskott\u2010Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein\u20101 and formyl\u2010methionyl\u2010leucyl\u2010phenylalanine","volume":"161","author":"Badolato R.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83041-0"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.9.3234"},{"key":"e_1_2_5_6_1","unstructured":"European Society for Immunodeficiencies(2001) Diagnostic criteria for primary immunodeficiencies: Wiskott\u2013Aldrich syndrome. (www document) U.R.Lhttp:\/\/www.cbt.ki.se\/esid\/15was.html."},{"key":"e_1_2_5_7_1","first-page":"102","article-title":"Allogeneic bone marrow transplantation (BMT) for Wiskott\u2013Aldrich syndrome (WAS): comparison of outcomes by donor type","volume":"99","author":"Filipovich A.H.","year":"1997","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01503.x"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.52.5.390"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702473"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01193.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00767.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03269.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03269.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:18:17Z","timestamp":1697429897000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03269.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03269.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03269.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"2002-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}